Register Login

Novavax Inc (NVAX)

(10% Negative) Novavax Inc (NVAX) Announces Delay in delivery Trials for its COVID-19 vaccine Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Jan. 29, 2026, 8:43 p.m.

    📋 Novavax Inc (NVAX) - Clinical Trial Update

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 08:01:06

    Event Type: Clinical Trial Update

    Event Details:

    Novavax Inc (NVAX) Announces Clinical Trial Update Novavax Inc (NVAX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: delivery, plans
    • Diseases/Conditions: its COVID-19 vaccine, global health
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Pandemic-Related Challenges, Regulatory Process
    • Collaboration: Novavax
    • Updated Timeline: 2025-2026

    🔬 Clinical Development Pipeline (Novavax Inc):

    Product Type Development Stage Therapeutic Area Source
    Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing) BIOLOGICAL Phase PHASE4 COVID-19 ClinicalTrials.gov
    protein subunit: Novavax COVID-19 vaccine BIOLOGICAL Phase PHASE4 COVID-19 ClinicalTrials.gov
    Novavax COVID-19 vaccine (2023-2024 formula XBB containing) BIOLOGICAL Phase PHASE4 COVID-19 ClinicalTrials.gov
    NVX-CoV2372 BIOLOGICAL Phase PHASE2 Immunosuppression ClinicalTrials.gov
    Placebo BIOLOGICAL Phase PHASE2 Seasonal Influenza ClinicalTrials.gov
    Influenza VLP Vaccine BIOLOGICAL Phase PHASE2 Seasonal Influenza ClinicalTrials.gov
    A/H1N1 2009 Influenza VLP Vaccine BIOLOGICAL Phase PHASE2 Seasonal Influenza ClinicalTrials.gov
    RSV-F Particle Vaccine BIOLOGICAL Phase PHASE1 Respiratory Syncytial Virus Infections ClinicalTrials.gov
    cTIV BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    Novavax Trivalent vaccine BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    Novavax Quadrivalent vaccine BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    TIV BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    H5N1 VLP Vaccine BIOLOGICAL Phase PHASE1 Pandemic Influenza ClinicalTrials.gov
    Influenza VLP Vaccine (recombinant) BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    Placebo (0.5mL injection) BIOLOGICAL Phase PHASE1 Respiratory Synctial Virus ClinicalTrials.gov
    Hepatitis A Vaccine (0.5mL injection) BIOLOGICAL Phase PHASE1 Respiratory Synctial Virus ClinicalTrials.gov
    RSV F Vaccine (0.5mL injection) BIOLOGICAL Phase PHASE1 Respiratory Synctial Virus ClinicalTrials.gov
    RSV F Vaccine with adjuvant (0.5mL injection) BIOLOGICAL Phase PHASE1 Respiratory Synctial Virus ClinicalTrials.gov
    Saline Placebo BIOLOGICAL Phase PHASE1 Influenza (Pandemic) ClinicalTrials.gov
    Monovalent Avian Influenza VLP (H5N1); Adjuvant BIOLOGICAL Phase PHASE1 Influenza (Pandemic) ClinicalTrials.gov
    Monovalent Avian Influenza VLP (H5N1) BIOLOGICAL Phase PHASE1 Influenza (Pandemic) ClinicalTrials.gov
    Low dose RSV-F Vaccine with Adjuvant [Bedside Mixing] BIOLOGICAL Phase PHASE2 Respiratory Syncytial Virus (RSV) ClinicalTrials.gov
    High dose RSV-F Vaccine without Adjuvant BIOLOGICAL Phase PHASE2 Respiratory Syncytial Virus (RSV) ClinicalTrials.gov
    High dose RSV-F Vaccine with Adjuvant BIOLOGICAL Phase PHASE2 Respiratory Syncytial Virus (RSV) ClinicalTrials.gov
    Low dose RSV-F Vaccine without Adjuvant BIOLOGICAL Phase PHASE2 Respiratory Syncytial Virus (RSV) ClinicalTrials.gov
    Low dose RSV-F Vaccine with Adjuvant BIOLOGICAL Phase PHASE2 Respiratory Syncytial Virus (RSV) ClinicalTrials.gov
    Dose 4 of Aluminum Adjuvant BIOLOGICAL Phase PHASE2 Respiratory Syncytial Virus Infections ClinicalTrials.gov
    Dose 3 of Aluminum Adjuvant BIOLOGICAL Phase PHASE2 Respiratory Syncytial Virus Infections ClinicalTrials.gov
    Dose 2 of Aluminum Adjuvant BIOLOGICAL Phase PHASE2 Respiratory Syncytial Virus Infections ClinicalTrials.gov
    Dose 1 of Aluminum Adjuvant BIOLOGICAL Phase PHASE2 Respiratory Syncytial Virus Infections ClinicalTrials.gov
    High dose RSV F Antigen BIOLOGICAL Phase PHASE2 Respiratory Syncytial Virus Infections ClinicalTrials.gov
    Low dose RSV F Antigen BIOLOGICAL Phase PHASE2 Respiratory Syncytial Virus Infections ClinicalTrials.gov
    Matrix-M1™ adjuvant BIOLOGICAL Phase PHASE1 Influenza (Pandemic) ClinicalTrials.gov
    Monovalent Avian Influenza VLP (H7N9) BIOLOGICAL Phase PHASE1 Influenza (Pandemic) ClinicalTrials.gov
    Adjuvant 1 BIOLOGICAL Phase PHASE1 Avian Influenza ClinicalTrials.gov
    Placebo (Day 0 & Day 28); Seasonal TIV (Day 0) BIOLOGICAL Phase PHASE1 Respiratory Syncytial Virus (RSV) ClinicalTrials.gov
    High dose RSV-F Vaccine without Adjuvant (Day 0); Seasonal TIV (Day 0 & Day 28) BIOLOGICAL Phase PHASE1 Respiratory Syncytial Virus (RSV) ClinicalTrials.gov
    High dose RSV-F Vaccine with Adjuvant (Day 0); Seasonal TIV (Day 0 & Day 28) BIOLOGICAL Phase PHASE1 Respiratory Syncytial Virus (RSV) ClinicalTrials.gov
    Low dose RSV-F Vaccine without Adjuvant (Day 0); Seasonal TIV (Day 0 & day 28) BIOLOGICAL Phase PHASE1 Respiratory Syncytial Virus (RSV) ClinicalTrials.gov
    Low dose RSV-F Vaccine with Adjuvant (Day 0); Seasonal TIV (Day 0 & Day 28) BIOLOGICAL Phase PHASE1 Respiratory Syncytial Virus (RSV) ClinicalTrials.gov
    Comparator TIV BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    Quadrivalent VLP Vaccine BIOLOGICAL Phase PHASE2 Influenza ClinicalTrials.gov
    SARS-CoV-2 rS/Matrix-M1 Adjuvant BIOLOGICAL Phase PHASE2 SARS-CoV-2 Infection ClinicalTrials.gov
    Matrix-M Adjuvant BIOLOGICAL Phase PHASE1 Ebola ClinicalTrials.gov
    8x Base Dose EBOV GP Vaccine BIOLOGICAL Phase PHASE1 Ebola ClinicalTrials.gov
    4x Base Dose EBOV GP Vaccine BIOLOGICAL Phase PHASE1 Ebola ClinicalTrials.gov
    2x Base Dose EBOV GP Vaccine BIOLOGICAL Phase PHASE1 Ebola ClinicalTrials.gov
    Base Dose EBOV GP Vaccine BIOLOGICAL Phase PHASE1 Ebola ClinicalTrials.gov
    Saline Placebo (0.5mL injection) DRUG Phase PHASE2 Respiratory Syncytial Virus Infections ClinicalTrials.gov
    Phosphate Buffer OTHER Phase PHASE2 Respiratory Syncytial Viruses ClinicalTrials.gov
    Matrix-M1 Adjuvant BIOLOGICAL Phase PHASE2 Respiratory Syncytial Viruses ClinicalTrials.gov
    RSV F Vaccine BIOLOGICAL Phase PHASE2 Respiratory Syncytial Viruses ClinicalTrials.gov
    RSV F Vaccine with Aluminum Phosphate Adjuvant BIOLOGICAL Phase PHASE2 Respiratory Syncytial Viruses ClinicalTrials.gov
    RSV-F Vaccine BIOLOGICAL Phase PHASE2 Respiratory Syncytial Virus (RSV) ClinicalTrials.gov
    Phosphate Buffer Placebo BIOLOGICAL Phase PHASE2 Respiratory Syncytial Virus (RSV) ClinicalTrials.gov
    SII B.1.617.2 BIOLOGICAL Phase PHASE1 Covid19 ClinicalTrials.gov
    SII Bivalent BIOLOGICAL Phase PHASE1 Covid19 ClinicalTrials.gov
    SII B.1.351 BIOLOGICAL Phase PHASE1 Covid19 ClinicalTrials.gov
    Saline - Day 21 OTHER Phase PHASE1 Influenza ClinicalTrials.gov
    Fluzone HD - Day 21 BIOLOGICAL Phase PHASE1 Influenza ClinicalTrials.gov
    Fluzone HD - Day 0 BIOLOGICAL Phase PHASE1 Influenza ClinicalTrials.gov
    NanoFlu BIOLOGICAL Phase PHASE1 Influenza ClinicalTrials.gov
    SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 2 BIOLOGICAL Phase PHASE1 COVID-19 ClinicalTrials.gov
    Normal saline solution (NSS), Placebo, Day 21 - Phase 1 OTHER Phase PHASE1 COVID-19 ClinicalTrials.gov
    SARS-CoV-2 rS/Matrix-M Adjuvant, Day 0 - Phase 1 BIOLOGICAL Phase PHASE1 COVID-19 ClinicalTrials.gov
    Normal saline solution (NSS), Placebo - Phase 2 OTHER Phase PHASE1 COVID-19 ClinicalTrials.gov
    Normal saline solution (NSS), Placebo - Phase 1 OTHER Phase PHASE1 COVID-19 ClinicalTrials.gov
    SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 1 BIOLOGICAL Phase PHASE1 COVID-19 ClinicalTrials.gov
    SARS-CoV-2 rS - Phase 1 BIOLOGICAL Phase PHASE1 COVID-19 ClinicalTrials.gov
    BBIBP-CorV vaccine BIOLOGICAL Phase PHASE3 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) ClinicalTrials.gov
    NVX-CoV2373 BIOLOGICAL Phase PHASE3 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) ClinicalTrials.gov
    Fluzone Quadrivalent BIOLOGICAL Phase PHASE3 Influenza, Human ClinicalTrials.gov
    Influenza Vaccine BIOLOGICAL Phase PHASE2 Influenza, Human ClinicalTrials.gov
    Flublok Quadrivalent BIOLOGICAL Phase PHASE2 Influenza, Human ClinicalTrials.gov
    Fluzone HD BIOLOGICAL Phase PHASE2 Influenza, Human ClinicalTrials.gov
    NanoFlu (Quad-NIV) BIOLOGICAL Phase PHASE2 Influenza, Human ClinicalTrials.gov
    Verorab Rabies Vaccine BIOLOGICAL Phase PHASE1 Malaria,Falciparum ClinicalTrials.gov
    Pfs230D1-EPA/Matrix-M Vaccine BIOLOGICAL Phase PHASE1 Malaria,Falciparum ClinicalTrials.gov
    XBB.1.5 Vaccine (single dose) BIOLOGICAL Phase PHASE2 COVID-19 ClinicalTrials.gov
    XBB.1.5 Vaccine (Booster) BIOLOGICAL Phase PHASE2 COVID-19 ClinicalTrials.gov
    SARS-CoV-2 rS Vaccine with Matrix-M Adjuvant DRUG Phase PHASE2 COVID-19 ClinicalTrials.gov
    Placebo Comparator OTHER Phase PHASE2 COVID-19 ClinicalTrials.gov
    CIC Vaccine with Matrix-M Adjuvant DRUG Phase PHASE2 COVID-19 ClinicalTrials.gov
    qNIV Vaccine with Matrix-M Adjuvant DRUG Phase PHASE2 COVID-19 ClinicalTrials.gov
    NVX-CoV2373 + NVX-CoV2540 DRUG Phase PHASE3 COVID-19 ClinicalTrials.gov
    NVX-CoV2540 DRUG Phase PHASE3 COVID-19 ClinicalTrials.gov
    NVX-CoV2373 + NVX-CoV2515 DRUG Phase PHASE3 COVID-19 ClinicalTrials.gov
    NVX-CoV2515 DRUG Phase PHASE3 COVID-19 ClinicalTrials.gov
    SARS-CoV-2 rS/Matrix-M1 Adjuvant (Second Booster Vaccination) BIOLOGICAL Phase PHASE3 SARS-CoV Infection ClinicalTrials.gov
    SARS-CoV-2 rS/Matrix-M1 Adjuvant (Booster Vaccination) BIOLOGICAL Phase PHASE3 SARS-CoV Infection ClinicalTrials.gov
    Placebo (Crossover Vaccination period) OTHER Phase PHASE3 SARS-CoV Infection ClinicalTrials.gov
    SARS-CoV-2 rS/Matrix-M1 Adjuvant (Crossover Vaccination period) BIOLOGICAL Phase PHASE3 SARS-CoV Infection ClinicalTrials.gov
    Placebo (Initial Vaccination Period) OTHER Phase PHASE3 SARS-CoV Infection ClinicalTrials.gov
    SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period) BIOLOGICAL Phase PHASE3 SARS-CoV Infection ClinicalTrials.gov
    R0.6C transmission blocking vaccine BIOLOGICAL Phase PHASE1 Malaria ClinicalTrials.gov
    Licensed seasonal influenza vaccine BIOLOGICAL Phase PHASE3 SARS-CoV-2 Infection ClinicalTrials.gov
    SARS-CoV-2 rS/Matrix M1-Adjuvant BIOLOGICAL Phase PHASE3 SARS-CoV-2 Infection ClinicalTrials.gov
    NVX-CoV2705 Vaccine BIOLOGICAL Phase PHASE3 Severe Acute Respiratory Syndrome Coronavirus 2 Infection ClinicalTrials.gov
    NVX-CoV2705 BIOLOGICAL Phase PHASE4 COVID-19 ClinicalTrials.gov
    Prototype/XBB.1.5 Bivalent Vaccine (5 µg) BIOLOGICAL Phase PHASE3 COVID-19 ClinicalTrials.gov
    NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine BIOLOGICAL Phase PHASE3 COVID-19 ClinicalTrials.gov
    Bivalent BA.4/5 BIOLOGICAL Phase PHASE2 COVID-19 ClinicalTrials.gov
    NVX-CoV2601(50μg) BIOLOGICAL Phase PHASE2 COVID-19 ClinicalTrials.gov
    NVX-CoV2601(35μg) BIOLOGICAL Phase PHASE2 COVID-19 ClinicalTrials.gov
    NVX-CoV2601 (35μg) BIOLOGICAL Phase PHASE2 COVID-19 ClinicalTrials.gov
    NVX-CoV2601(5μg) BIOLOGICAL Phase PHASE2 COVID-19 ClinicalTrials.gov
    NVX-CoV2601 (5μg) BIOLOGICAL Phase PHASE2 COVID-19 ClinicalTrials.gov
    NVX-CoV2373 (5μg) BIOLOGICAL Phase PHASE2 COVID-19 ClinicalTrials.gov
    Formulation buffer BIOLOGICAL Phase PHASE3 Respiratory Syncytial Virus Infections ClinicalTrials.gov
    RSV F vaccine with adjuvant BIOLOGICAL Phase PHASE3 Respiratory Syncytial Virus Infections ClinicalTrials.gov
    Fluzone HD trivalent BIOLOGICAL Phase PHASE2 COVID-19 ClinicalTrials.gov
    coformulated CIC Vaccine BIOLOGICAL Phase PHASE2 COVID-19 ClinicalTrials.gov
    Pfizer mRNA COVID-19 vaccine BIOLOGICAL Phase PHASE4 COVID-19 ClinicalTrials.gov
    tNIV 1 and Matrix-M Adjuvant BIOLOGICAL Phase PHASE2 COVID-19 ClinicalTrials.gov
    Fluzone High Dose BIOLOGICAL Phase PHASE3 COVID-19 ClinicalTrials.gov
    tNIV Vaccine BIOLOGICAL Phase PHASE3 COVID-19 ClinicalTrials.gov
    Novavax COVID-19 Vaccine BIOLOGICAL Phase PHASE3 COVID-19 ClinicalTrials.gov
    CIC Vaccine Co-formulated tNIV2 , SARSCoV-2 rS and Matrix-M Adjuvant BIOLOGICAL Phase PHASE3 COVID-19 ClinicalTrials.gov
    SARS-CoV-2 rS antigen/Matrix-M Adjuvant BIOLOGICAL Phase PHASE3 COVID-19 ClinicalTrials.gov
    SARS-CoV-2 rS Nanoparticle Vaccine in-clinic mixed with Matrix-M1 Adjuvant BIOLOGICAL Phase PHASE1 SARS-CoV Infection ClinicalTrials.gov
    qNIV Nanoparticle Vaccine2 in-clinic mixed with Matrix-M1 Adjuvant BIOLOGICAL Phase PHASE1 SARS-CoV Infection ClinicalTrials.gov
    ICC Vaccine BIOLOGICAL Phase PHASE1 SARS-CoV Infection ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Novavax Inc
    • Ticker Symbol: NVAX

Search

News categories